Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease
暂无分享,去创建一个
C. Caltagirone | L. Brusa | M. Oliveri | P. Stanzione | C. Caltagirone | E. Lo Gerfo | G. Koch | E. L. Gerfo | M. Oliveri | F. Carrillo | P. Mir | S. Torriero | L. Brusa | P. Stanzione | G. Koch | F. Carrillo | E. Lo Gerfo | S. Torriero | P. Mir
[1] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[2] J R Moeller,et al. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. , 2001, Brain : a journal of neurology.
[3] Deborah C Mash,et al. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT‐PCR , 2003, The European journal of neuroscience.
[4] R. Mailman,et al. Task specific influences of Parkinson’s disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries , 2007, Neuroscience.
[5] C. Marsden,et al. Corticocortical inhibition in human motor cortex. , 1993, The Journal of physiology.
[6] Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease. , 2001, Archives of neurology.
[7] M. Hallett,et al. Human motor evoked responses to paired transcranial magnetic stimuli. , 1992, Electroencephalography and clinical neurophysiology.
[8] J. Dostrovsky,et al. Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine. , 2000, Annals of neurology.
[9] R. Hanajima,et al. Magnetic stimulation over the cerebellum in humans , 1995, Annals of neurology.
[10] D. Brooks,et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. , 2000, The New England journal of medicine.
[11] Sara Torriero,et al. Increased facilitation of the primary motor cortex following 1Hz repetitive transcranial magnetic stimulation of the contralateral cerebellum in normal humans , 2005, Neuroscience Letters.
[12] P. Remy,et al. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT‐PD) , 1999, Movement disorders : official journal of the Movement Disorder Society.
[13] Emanuele Lo Gerfo,et al. Changes in intracortical circuits of the human motor cortex following theta burst stimulation of the lateral cerebellum , 2008, Clinical Neurophysiology.
[14] Ulf Ziemann,et al. The role of GABA(B) receptors in intracortical inhibition in the human motor cortex. , 2006, Experimental brain research.
[15] S Fahn,et al. The spectrum of levodopa-induced dyskinesias. , 2000, Annals of neurology.
[16] C. Tsai,et al. Pallidotomy effect on the cortical excitability in patients with severe Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[17] C Caltagirone,et al. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease , 2005, Neurology.
[18] M. S. Young,et al. Stereotactic pallidotomy lengthens the transcranial magnetic cortical stimulation silent period in Parkinson's disease , 1997, Neurology.
[19] Patrick Ragert,et al. Contribution of transcranial magnetic stimulation to the understanding of cortical mechanisms involved in motor control , 2008, The Journal of physiology.
[20] Ji Hyun Ko,et al. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: The contribution of expectation , 2006, NeuroImage.
[21] R A Bakay,et al. Ablative surgery and deep brain stimulation for Parkinson's disease. , 1999, Neurosurgery.
[22] P. Strick,et al. The cerebellum communicates with the basal ganglia , 2005, Nature Neuroscience.
[23] T. Tominaga,et al. The role of sigma-receptors in levodopa-induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study. , 2004, Journal of neurosurgery.
[24] M. Desmurget,et al. Motor urgency is mediated by the contralateral cerebellum in Parkinson’s disease , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[25] Paul Greengard,et al. Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia , 2003, Nature Neuroscience.
[26] J. Rothwell,et al. Theta Burst Stimulation of the Human Motor Cortex , 2005, Neuron.
[27] J. Obeso,et al. L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease. , 2008, Neurosurgery.
[28] Masao Ito. Control of mental activities by internal models in the cerebellum , 2008, Nature Reviews Neuroscience.
[29] Viviana Versace,et al. Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson’s disease , 2006, Clinical Neurophysiology.
[30] D. Centonze,et al. Mechanisms of Disease: basic-research-driven investigations in humans—the case of hyperkinetic disorders , 2007, Nature Clinical Practice Neurology.
[31] A. E. Lang,et al. Breast cancer at site of implanted vagus nerve stimulator , 2007, Neurology.
[32] O Rascol. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group , 2000 .
[33] Alexander Münchau,et al. Repeated premotor rTMS leads to cumulative plastic changes of motor cortex excitability in humans , 2003, NeuroImage.
[34] John C Rothwell,et al. Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.
[35] T. Tominaga,et al. The role of σ-receptors in levodopa-induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study , 2004 .
[36] J. Rothwell,et al. Techniques and mechanisms of action of transcranial stimulation of the human motor cortex , 1997, Journal of Neuroscience Methods.
[37] J Valls-Solé,et al. Akinesia in Parkinson's disease. II. Effects of subthreshold repetitive transcranial motor cortex stimulation , 1994, Neurology.
[38] Erwan Bezard,et al. Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies , 2001, Nature Reviews Neuroscience.
[39] P. Ashby,et al. Pallidotomy Increases Cortical Inhibition in Parkinson's Disease , 1997, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[40] Hong Yu,et al. Role of hyperactive cerebellum and motor cortex in Parkinson's disease , 2007, NeuroImage.
[41] J. Rothwell,et al. Clinical applications of transcranial magnetic stimulation in patients with movement disorders , 2008, The Lancet Neurology.
[42] D J Brooks,et al. Neuroimaging of dyskinesia. , 2000, Annals of neurology.